St. Elisabeth Ziekenhuis

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials
• Crohn's disease1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting

Closed trials

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source